Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Exercise/Conversion of 19,000 PCVX shares, $492.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Vaxcyte, Inc. (PCVX) | Exercise/Conversion | 19,000 | $492.5K |
| Sep 9, 2026 | Vaxcyte, Inc. (PCVX) | Tax Withholding | 1,327 | $80.1K |
| Sep 2, 2026 | Vaxcyte, Inc. (PCVX) | Tax Withholding | 243 | $14.8K |
| Apr 8, 2026 | Vaxcyte, Inc. (PCVX) | Exercise/Conversion | 3,000 | $77.8K |
| Mar 18, 2026 | Vaxcyte, Inc. (PCVX) | Sale | 1,487 | $82.4K |
| Mar 11, 2026 | Vaxcyte, Inc. (PCVX) | Tax Withholding | 495 | $29.4K |
| Mar 3, 2026 | Vaxcyte, Inc. (PCVX) | Grant/Award | 10,681 | n/a |
| Dec 29, 2025 | Vaxcyte, Inc. (PCVX) | Sale | 4,907 | $235.0K |
| Sep 10, 2025 | Vaxcyte, Inc. (PCVX) | Tax Withholding | 482 | $15.6K |
| Sep 4, 2025 | Vaxcyte, Inc. (PCVX) | Tax Withholding | 242 | $7.6K |